Compare BIO & KBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | KBR |
|---|---|---|
| Founded | 1952 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Military/Government/Technical |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 4.8B |
| IPO Year | 1994 | 2006 |
| Metric | BIO | KBR |
|---|---|---|
| Price | $376.97 | $36.14 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 8 |
| Target Price | ★ $339.75 | $52.43 |
| AVG Volume (30 Days) | 221.5K | ★ 988.3K |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.83% |
| EPS Growth | ★ 142.61 | 15.05 |
| EPS | N/A | ★ 1.55 |
| Revenue | $2,583,200,000.00 | ★ $5,767,000,000.00 |
| Revenue This Year | $2.74 | $4.56 |
| Revenue Next Year | $3.20 | $5.11 |
| P/E Ratio | ★ N/A | $23.99 |
| Revenue Growth | 0.65 | ★ 2.27 |
| 52 Week Low | $236.73 | $29.94 |
| 52 Week High | $396.23 | $52.23 |
| Indicator | BIO | KBR |
|---|---|---|
| Relative Strength Index (RSI) | 61.25 | 42.91 |
| Support Level | $287.41 | $35.91 |
| Resistance Level | $396.23 | $36.67 |
| Average True Range (ATR) | 11.06 | 0.92 |
| MACD | -2.58 | -0.23 |
| Stochastic Oscillator | 52.33 | 8.44 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
KBR, formerly Kellogg Brown & Root, is a global provider of technology, integrated engineering, procurement, and construction delivery, and operations and maintenance services. The company's business is organized into two segments: mission technology solutions and sustainable technology solutions. KBR has operations in over 30 countries and employs approximately 36,000 people. The firm generated $7.8 billion in revenue in 2025.